G. Arnett

416 total citations
19 papers, 337 citations indexed

About

G. Arnett is a scholar working on Epidemiology, Organic Chemistry and Oncology. According to data from OpenAlex, G. Arnett has authored 19 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in G. Arnett's work include Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). G. Arnett is often cited by papers focused on Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). G. Arnett collaborates with scholars based in United States. G. Arnett's co-authors include William M. Shannon, R W Brockman, R. W. Sidwell, Sue C. Shaddix, Paula W. Allan, L. Lee Bennett, Y. Fulmer Shealy, Louise Westbrook, F. M. Schabel and John A. Montgomery and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

G. Arnett

19 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Arnett United States 11 145 127 96 91 69 19 337
M. R. HARNDEN United Kingdom 10 197 1.4× 117 0.9× 139 1.4× 124 1.4× 45 0.7× 29 390
Nils‐Gunnar Johansson Sweden 14 263 1.8× 168 1.3× 143 1.5× 175 1.9× 55 0.8× 20 591
Jan Olof Noren Sweden 6 231 1.6× 167 1.3× 90 0.9× 164 1.8× 39 0.6× 8 474
Yael Teitz Israel 12 48 0.3× 147 1.2× 100 1.0× 56 0.6× 110 1.6× 28 351
G. E. Underwood United States 13 230 1.6× 98 0.8× 100 1.0× 67 0.7× 127 1.8× 27 541
Erik Helgstrand Sweden 9 315 2.2× 210 1.7× 113 1.2× 210 2.3× 57 0.8× 20 607
Margaret Fox United States 6 135 0.9× 102 0.8× 70 0.7× 105 1.2× 67 1.0× 9 385
Iain S. Sim United States 11 219 1.5× 218 1.7× 147 1.5× 204 2.2× 28 0.4× 25 565
Shahnaz Rahim United Kingdom 11 182 1.3× 172 1.4× 171 1.8× 91 1.0× 113 1.6× 19 456
Gussie Arnett United States 12 174 1.2× 255 2.0× 165 1.7× 192 2.1× 61 0.9× 20 507

Countries citing papers authored by G. Arnett

Since Specialization
Citations

This map shows the geographic impact of G. Arnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Arnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Arnett more than expected).

Fields of papers citing papers by G. Arnett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Arnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Arnett. The network helps show where G. Arnett may publish in the future.

Co-authorship network of co-authors of G. Arnett

This figure shows the co-authorship network connecting the top 25 collaborators of G. Arnett. A scholar is included among the top collaborators of G. Arnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Arnett. G. Arnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kwong, Cecil D., Charles A. Krauth, G. Arnett, et al.. (1998). ChemInform Abstract: Synthesis and Antiviral Evaluation of Analogues of Adenosine‐N1‐oxide and 1‐(Benzyloxy)adenosine.. ChemInform. 29(45). 2 indexed citations
2.
3.
Allen, Lois B., et al.. (1992). Novel method for evaluating antiviral drugs against human cytomegalovirus in mice. Antimicrobial Agents and Chemotherapy. 36(1). 206–208. 14 indexed citations
4.
Parker, William B., Sue C. Shaddix, Paula W. Allan, et al.. (1992). Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.. Molecular Pharmacology. 41(2). 245–251. 8 indexed citations
5.
Shealy, Y. Fulmer, Joe D. Clayton, G. Arnett, & William M. Shannon. (1984). ChemInform Abstract: SYNTHESIS AND ANTIVIRAL EVALUATION OF CARBOCYCLIC ANALOGS OF RIBOFURANOSIDES OF 2‐AMINO‐6‐SUBSTITUTED‐PURINES AND OF 2‐AMINO‐6‐SUBSTITUTED‐8‐AZAPURINES. Chemischer Informationsdienst. 15(45). 8 indexed citations
6.
Baker, David C., William Waites, G. Arnett, et al.. (1984). ChemInform Abstract: SYNTHESIS AND EVALUATION OF A SERIES OF 2′‐O‐ACYL DERIVATIVES OF 9‐β‐D‐ARABINOFURANOSYLADENINE AS ANTIHERPES AGENTS. Chemischer Informationsdienst. 15(32). 2 indexed citations
7.
Shannon, William M., et al.. (1983). Evaluation of prodrugs of 9-beta-D-arabinofuranosyladenine for therapeutic efficacy in the topical treatment of genital herpesvirus infections in guinea pigs. Antimicrobial Agents and Chemotherapy. 24(5). 706–712. 8 indexed citations
8.
9.
Shannon, William M., et al.. (1982). Lack of efficacy of 2-deoxy-D-glucose in the treatment of experimental herpes genitalis in guinea pigs. Antimicrobial Agents and Chemotherapy. 21(3). 513–515. 14 indexed citations
10.
Shannon, William M., G. Arnett, Louise Westbrook, et al.. (1981). Evaluation of carbodine, the carbocyclic analog of cytidine, and related carbocyclic analogs of pyrimidine nucleosides for antiviral activity against human influenza Type A viruses. Antimicrobial Agents and Chemotherapy. 20(6). 769–776. 41 indexed citations
11.
Shannon, William M., G. Arnett, F. M. Schabel, Thomas W. North, & Shira Cohen. (1980). Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice. Antimicrobial Agents and Chemotherapy. 18(4). 598–603. 9 indexed citations
12.
Montgomery, John A., Anita T. Shortnacy, G. Arnett, & William M. Shannon. (1977). 2-Substituted derivatives of 9-.alpha.-D-arabinofuranosyladenine and 9-.alpha.-D-arabinofuranosyl-8-azaadenine. Journal of Medicinal Chemistry. 20(3). 401–404. 11 indexed citations
13.
Bennett, L. Lee, William M. Shannon, Paula W. Allan, & G. Arnett. (1975). STUDIES ON THE BIOCHEMICAL BASIS FOR THE ANTIVIRAL ACTIVITIES OF SOME NUCLEOSIDE ANALOGS*. Annals of the New York Academy of Sciences. 255(1). 342–358. 59 indexed citations
14.
Shannon, William M., Anita T. Shortnacy, G. Arnett, & John A. Montgomery. (1974). Antiviral agents. 1-Aralkyloxyadenosines. Journal of Medicinal Chemistry. 17(3). 361–363. 10 indexed citations
15.
Sidwell, R. W., G. Arnett, & F. M. Schabel. (1972). <i>In vitro</i> Effect of a Variety of Biologically Active Compounds on Human Cytomegalovirus. Chemotherapy. 17(4). 259–282. 11 indexed citations
16.
Brockman, R W, R. W. Sidwell, G. Arnett, & Sue C. Shaddix. (1970). Heterocyclic Thiosemicarbazones: Correlation Between Structure, Inhibition of Ribonucleotide Reductase, and Inhibition of DNA Viruses. Experimental Biology and Medicine. 133(2). 609–614. 76 indexed citations
17.
Dixon, Glen J., et al.. (1968). Antiviral Activity of Carbobenzoxy Di- and Tripeptides on Measles Virus. Applied Microbiology. 16(10). 1489–1496. 26 indexed citations
18.
Sidwell, Robert W., G. Arnett, & Glen J. Dixon. (1966). In Vitro Studies on the Antiviral Activity of 1,3-Bis(2-Chloroethyl)-1-Nitrosourea. Applied Microbiology. 14(3). 405–410. 3 indexed citations
19.
Sidwell, Robert W., G. Arnett, & Glen J. Dixon. (1966). In Vitro Studies on the Antiviral Activity of 1,3-Bis(2-Chloroethyl)-1-Nitrosourea. Applied Microbiology. 14(3). 405–410. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. R. HARNDEN Breakdown of academic impact, for papers by Nils‐Gunnar Johansson Breakdown of academic impact, for papers by Jan Olof Noren Breakdown of academic impact, for papers by Yael Teitz Breakdown of academic impact, for papers by G. E. Underwood Breakdown of academic impact, for papers by Erik Helgstrand Breakdown of academic impact, for papers by Margaret Fox Breakdown of academic impact, for papers by Iain S. Sim Breakdown of academic impact, for papers by Shahnaz Rahim Breakdown of academic impact, for papers by Gussie Arnett
Rankless by CCL
2026